
Phathom Pharmaceuticals, Inc. — Investor Relations & Filings
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for acid-related gastrointestinal (GI) diseases. The company's primary efforts are centered on advancing its lead product candidate, vonoprazan, a potassium-competitive acid blocker (P-CAB). This therapeutic is developed for a range of indications, including the treatment of erosive esophagitis, Helicobacter pylori (H. pylori) infection, and non-erosive reflux disease. Phathom aims to transform the treatment landscape for these conditions by addressing unmet medical needs and improving patient outcomes with innovative therapeutic options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46753467 | 8-K | 2026-05-21 | English | ||
| 39071239 | 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 39071212 | 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 33707039 | ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33706792 | DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33065545 | S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English | ||
| 32898205 | 4 - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-03-03 | English | ||
| 32898207 | 10-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 32898206 | 8-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 31697143 | 4 Filing | 2026-02-12 | English | ||
| 31697060 | 4 Filing | 2026-02-12 | English | ||
| 31697051 | SCHEDULE 13G/A Filing | 2026-01-27 | English | ||
| 31696987 | 4 Filing | 2026-01-27 | English | ||
| 31696930 | 4 Filing | 2026-01-23 | English | ||
| 13192726 | 4 | 2026-01-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
|
Beleave Inc.
Vertically integrated cannabis company engaged in cultivati…
|
BLEVF | CA | Manufacturing |
|
BELITE BIO, INC
Clinical-stage biopharma developing therapies for retinal a…
|
BLTE | KY | Manufacturing |
|
Benitec Biopharma Inc.
A clinical-stage biotech developing genetic medicines to si…
|
BNTC | US | Manufacturing |
|
BeOne Medicines Ltd.
Global oncology company that discovers, develops, and deliv…
|
ONC | KY | Manufacturing |
|
BEONE MEDICINES LTD.
Biopharmaceutical firm developing targeted oncology therapi…
|
688235 | CN | Manufacturing |
|
BerGenBio
Clinical-stage biopharma that developed selective AXL kinas…
|
BGBIO | NO | Manufacturing |
|
Beryl Drugs Ltd.
Manufactures IV fluids and small volume parenterals for cli…
|
524606 | IN | Manufacturing |
|
BESHOM HOLDINGS BERHAD
An investment holding company with diversified operations i…
|
— | MY | Manufacturing |
|
Besunyen Holdings Company Limited
Leading supplier of functional health teas, weight manageme…
|
926 | HK | Manufacturing |
Phathom Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32407/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32407 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32407 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32407 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32407}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Phathom Pharmaceuticals, Inc. (id: 32407)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.